Ethical and legal implications of whole genome and whole exome sequencing in African populations

BMC Medical Ethics

Nicki Tiffin¹  Adebowale A Adeyemo³  Pieter GJ Koornhof²  Galen EB Wright¹ 

[1] South African National Bioinformatics Institute, University of the Western Cape, Bellville, South Africa;Department of Mercantile and Labour Law, University of the Western Cape, Bellville, South Africa;Center for Research on Genomics and Global Health, National Institutes of Health/National Human Genome Research Institute, Bethesda, MD, USA

关键词: Whole genome and whole exome sequencing;    Next generation sequencing;    and societal issues;    legal;    Ethical;    African populations;   

Others  :  799947
DOI  :  10.1186/1472-6939-14-21

 received in 2013-01-24, accepted in 2013-05-20,  发布年份 2013

【 摘 要 】

Background

Rapid advances in high throughput genomic technologies and next generation sequencing are making medical genomic research more readily accessible and affordable, including the sequencing of patient and control whole genomes and exomes in order to elucidate genetic factors underlying disease. Over the next five years, the Human Heredity and Health in Africa (H3Africa) Initiative, funded by the Wellcome Trust (United Kingdom) and the National Institutes of Health (United States of America), will contribute greatly towards sequencing of numerous African samples for biomedical research.

Discussion

Funding agencies and journals often require submission of genomic data from research participants to databases that allow open or controlled data access for all investigators. Access to such genotype-phenotype and pedigree data, however, needs careful control in order to prevent identification of individuals or families. This is particularly the case in Africa, where many researchers and their patients are inexperienced in the ethical issues accompanying whole genome and exome research; and where an historical unidirectional flow of samples and data out of Africa has created a sense of exploitation and distrust. In the current study, we analysed the implications of the anticipated surge of next generation sequencing data in Africa and the subsequent data sharing concepts on the protection of privacy of research subjects. We performed a retrospective analysis of the informed consent process for the continent and the rest-of-the-world and examined relevant legislation, both current and proposed. We investigated the following issues: (i) informed consent, including guidelines for performing culturally-sensitive next generation sequencing research in Africa and availability of suitable informed consent documents; (ii) data security and subject privacy whilst practicing data sharing; (iii) conveying the implications of such concepts to research participants in resource limited settings.

Summary

We conclude that, in order to meet the unique requirements of performing next generation sequencing-related research in African populations, novel approaches to the informed consent process are required. This will help to avoid infringement of privacy of individual subjects as well as to ensure that informed consent adheres to acceptable data protection levels with regard to use and transfer of such information.

【 授权许可】

   
2013 Wright et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Tennessen JA, Bigham AW, O’Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do R, Liu X, Jun G: Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012, 337:64-69.
• [2]Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz CM, Fryer-Edwards K, Green SK, Hodosh MA: Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol 2008, 6:e73.
• [3]Green ED, Guyer MS: National Human Genome Research Institute: Charting a course for genomic medicine from base pairs to bedside. Nature 2011, 470:204-213.
• [4]Tabor HK, Berkman BE, Hull SC, Bamshad MJ: Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research. Am J Med Genet A 2011, 155A:2916-2924.
• [5]Sirugo G, Hennig BJ, Adeyemo AA, Matimba A, Newport MJ, Ibrahim ME, Ryckman KK, Tacconelli A, Mariani-Costantini R, Novelli G, Soodyall H, Rotimi CN, Ramesar RS, Tishkoff SA, Williams SM: Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet 2008, 123:557-598.
• [6]Rotimi CN, Jorde LB: Ancestry and disease in the age of genomic medicine. N Engl J Med 2010, 363:1551-1558.
• [7]H3Africa: Human Heredity and Health in Africa. http://www.h3africa.org/ webcite
• [8]NIH News: First recipients of research grants to support genomic studies in Africa announced. http://www.genome.gov/27550933 webcite
• [9]McGuire AL, Beskow LM: Informed consent in genomics and genetic research. Annu Rev Genomics Hum Genet 2010, 11:361-381.
• [10]US Department of Health and Human Services Policy for the Protection of Human Research Subjects Code of Federal Regulations, 45 CFR Part 46. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html webcite
• [11]H3Africa Funding: Informed Consent. http://h3africa.org/informedConsent.cfm webcite
• [12]The Belmont Report. http://www.hhs.gov/ohrp/policy/belmont.html webcite
• [13]Federal Policy for the Protection of Human Subjects (’Common Rule’). http://www.hhs.gov/ohrp/humansubjects/commonrule/index.html webcite
• [14]Kaye J, Heeney C, Hawkins N, De Vries J, Boddington P: Data sharing in genomics–re-shaping scientific practice. Nat Rev Genet 2009, 10:331-335.
• [15]SF424 (R&R) Application Guide for NIH and Other PHS Agencies. http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf webcite
• [16]Homer N, Szelinger S, Redman M, Duggan D, Tembe W, Muehling J, Pearson JV, Stephan DA, Nelson SF, Craig DW: Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet 2008, 4:e1000167.
• [17]Heeney C, Hawkins N, De Vries J, Boddington P, Kaye J: Assessing the privacy risks of data sharing in genomics. Public Health Genomics 2011, 14:17-25.
• [18]Malin BA: An evaluation of the current state of genomic data privacy protection technology and a roadmap for the future. J Am Med Inform Assoc 2005, 12:28-34.
• [19]Lowrance WW, Collins FS: Ethics. Identifiability in genomic research. Science 2007, 317:600-602.
• [20]Gitschier J: Inferential genotyping of Y chromosomes in Latter-Day Saints founders and comparison to Utah samples in the HapMap project. Am J Hum Genet 2009, 84:251-258.
• [21]Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y: Identifying Personal Genomes by Surname Inference. Science 2013, 339:321-324.
• [22]dbGAP: Data Use Certification. http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/about.html#duc webcite
• [23]The European Genome-Phenome Archive: Data Access Agreements. https://www.ebi.ac.uk/ega/data-access-agreement-daa-examples webcite
• [24]Loukides G, Denny JC, Malin B: The disclosure of diagnosis codes can breach research participants’ privacy. J Am Med Inform Assoc 2010, 17:322-327.
• [25]NHGRI Intramural Research Bioethics Core: Points to Consider in the Transition Toward Whole-Genome Sequencing in Human Subjects Research. http://www.genome.gov/Pages/Research/Intramural/IRB/WES-WGS_Points_to_Consider.pdf webcite
• [26]Tabor HK, Stock J, Brazg T, McMillin MJ, Dent KM, Yu J-H, Shendure J, Bamshad MJ: Informed consent for whole genome sequencing: a qualitative analysis of participant expectations and perceptions of risks, benefits, and harms. Am J Med Genet A 2012, 158A:1310-1319.
• [27]Trinidad SB, Fullerton SM, Ludman EJ, Jarvik GP, Larson EB, Burke W: Research ethics, Research practice and participant preferences: the growing gulf. Science 2011, 331:287-288.
• [28]Johnston JJ, Rubinstein WS, Facio FM, Ng D, Singh LN, Teer JK, Mullikin JC, Biesecker LG: Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet 2012, 91:97-108.
• [29]Wallace S, Lazor S, Knoppers BM: Consent and population genomics: the creation of generic tools. IRB 2009, 31:15-20.
• [30]Kaufman DJ, Murphy-Bollinger J, Scott J, Hudson KL: Public opinion about the importance of privacy in biobank research. Am J Hum Genet 2009, 85:643-654.
• [31]The International HapMap Project. http://hapmap.ncbi.nlm.nih.gov/ webcite
• [32]Liu F, Van der Lijn F, Schurmann C, Zhu G, Chakravarty MM, Hysi PG, Wollstein A, Lao O, De Bruijne M, Ikram MA, Van der Lugt A, Rivadeneira F, Uitterlinden AG, Hofman A, Niessen WJ, Homuth G, De Zubicaray G, McMahon KL, Thompson PM, Daboul A, Puls R, Hegenscheid K, Bevan L, Pausova Z, Medland SE, Montgomery GW, Wright MJ, Wicking C, Boehringer S, Spector TD: A genome-wide association study identifies five Loci influencing facial morphology in Europeans. PLoS Genet 2012, 8:e1002932.
• [33]Wolf SM: The past, present, and future of the debate over return of research results and incidental findings. Genet Med 2012, 14:355-357.
• [34]Wolf SM, Paradise J, Caga-anan C: The law of incidental findings in human subjects research: establishing researchers’ duties. J Law Med Ethics 2008, 36:361-383. 214
• [35]Beskow LM, Burke W: Offering individual genetic research results: context matters. Sci Transl Med 2010, 2:38. cm20
• [36]Fabsitz RR, McGuire A, Sharp RR, Puggal M, Beskow LM, Biesecker LG, Bookman E, Burke W, Burchard EG, Church G, Clayton EW, Eckfeldt JH, Fernandez CV, Fisher R, Fullerton SM, Gabriel S, Gachupin F, James C, Jarvik GP, Kittles R, Leib JR, O’Donnell C, O’Rourke PP, Rodriguez LL, Schully SD, Shuldiner AR, Sze RKF, Thakuria JV, Wolf SM, Burke GL: Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet 2010, 3:574-580.
• [37]Dressler LG, Smolek S, Ponsaran R, Markey JM, Starks H, Gerson N, Lewis S, Press N, Juengst E, Wiesner GL: IRB perspectives on the return of individual results from genomic research. Genet Med 2012, 14:215-222.
• [38]Lyon GJ: There is nothing “incidental” about unrelated findings. Pers Med 2012, 9:163-166.
• [39]Bredenoord AL, Onland-Moret NC, Van Delden JJM: Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy. Hum Mutat 2011, 32:861-867.
• [40]Wolf SM, Crock BN, Van Ness B, Lawrenz F, Kahn JP, Beskow LM, Cho MK, Christman MF, Green RC, Hall R, Illes J, Keane M, Knoppers BM, Koenig BA, Kohane IS, Leroy B, Maschke KJ, McGeveran W, Ossorio P, Parker LS, Petersen GM, Richardson HS, Scott JA, Terry SF, Wilfond BS, Wolf WA: Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 2012, 14:361-384.
• [41]Berg JS, Khoury MJ, Evans JP: Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time. Genet Med 2011, 13:499-504.
• [42]Solomon BD, Hadley DW, Pineda-Alvarez DE, Kamat A, Teer JK, Cherukuri PF, Hansen NF, Cruz P, Young AC, Berkman BE, Chandrasekharappa SC, Mullikin JC: Incidental medical information in whole-exome sequencing. Pediatrics 2012, 129:e1605-1611.
• [43]Clayton EW, McGuire AL: The legal risks of returning results of genomics research. Genet Med 2012, 14:473-477.
• [44]Brunham LR, Hayden MR: Medicine. Whole-genome sequencing: the new standard of care. Science 2012, 336:1112-1113.
• [45]Xue Y, Chen Y, Ayub Q, Huang N, Ball EV, Mort M, Phillips AD, Shaw K, Stenson PD, Cooper DN, Tyler-Smith C: Consortium the 1000 GP: Deleterious- and Disease-Allele Prevalence in Healthy Individuals: Insights from Current Predictions, Mutation Databases, and Population-Scale Resequencing. Am J Hum Genet 2012, 91:1022-1032.
• [46]My46. https://www.my46.org/ webcite
• [47]American College of Medical Genetics and Genomics. http://www.acmg.net webcite
• [48]Green RC, Berg JS, Berry GT, Biesecker LG, Dimmock DP, Evans JP, Grody WW, Hegde MR, Kalia S, Korf BR, Krantz I, McGuire AL, Miller DT, Murray MF, Nussbaum RL, Plon SE, Rehm HL, Jacob HJ: Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med 2012, 14:405-410.
• [49]Rotimi C, Leppert M, Matsuda I, Zeng C, Zhang H, Adebamowo C, Ajayi I, Aniagwu T, Dixon M, Fukushima Y, Macer D, Marshall P, Nkwodimmah C, Peiffer A, Royal C, Suda E, Zhao H, Wang VO, McEwen J: Community engagement and informed consent in the International HapMap project. Community Genet 2007, 10:186-198.
• [50]NHGRI Issues in Genetics: Special Informed Consent Considerations. http://www.genome.gov/27026636 webcite
• [51]Upshur REG, Lavery JV, Tindana PO: Taking tissue seriously means taking communities seriously. BMC Med Ethics 2007, 8:11. BioMed Central Full Text
• [52]Coetzee B, Kagee A, Tomlinson M, Warnich L, Ikediobi O: Reactions, beliefs and concerns associated with providing hair specimens for medical research among a South African sample: a qualitative approach. Futur Virol 2012, 7:1135-1142.
• [53]Nyika A: Ethical and practical challenges surrounding genetic and genomic research in developing countries. Acta Trop 2009, 112(Suppl 1):S21-31.
• [54]De Vries J, Bull SJ, Doumbo O, Ibrahim M, Mercereau-Puijalon O, Kwiatkowski D, Parker M: Ethical issues in human genomics research in developing countries. BMC Med Ethics 2011, 12:5. BioMed Central Full Text
• [55]Ross LF, Loup A, Nelson RM, Botkin JR, Kost R, Smith GR Jr, Gehlert S: Human subjects protections in community-engaged research: a research ethics framework. J Empir Res Hum Res Ethics 2010, 5:5-17.
• [56]Tindana PO, Singh JA, Tracy CS, Upshur REG, Daar AS, Singer PA, Frohlich J, Lavery JV: Grand challenges in global health: community engagement in research in developing countries. PLoS Med 2007, 4:e273.
• [57]Hardy B-J, Séguin B, Ramesar R, Singer PA, Daar AS: South Africa: from species cradle to genomic applications. Nat Rev Genet 2008, 9(1):S19-23.
• [58]Gureje O, Alem A: Mental health policy development in Africa. Bull World Health Organ 2000, 78:475-482.
• [59]Rankin WW, Brennan S, Schell E, Laviwa J, Rankin SH: The Stigma of Being HIV-Positive in Africa. PLoS Med 2005, 2:e247.
• [60]Menkiti IA: Person and community in African traditional thought. African philosophy: An introduction 1984., 3
• [61]Sankar P, Cho MK, Wolpe PR, Schairer C: What is in a cause? Exploring the relationship between genetic cause and felt stigma. Genet Med 2006, 8:33-42.
• [62]Tekola F, Bull S, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, Davey G: Impact of social stigma on the process of obtaining informed consent for genetic research on podoconiosis: a qualitative study. BMC Med Ethics 2009, 10:13. BioMed Central Full Text
• [63]Goldenberg AJ, Hull SC, Wilfond BS, Sharp RR: Patient perspectives on group benefits and harms in genetic research. Public Health Genomics 2011, 14:135-142.
• [64]De Vries J, Jallow M, Williams TN, Kwiatkowski D, Parker M, Fitzpatrick R: Investigating the potential for ethnic group harm in collaborative genomics research in Africa: is ethnic stigmatisation likely? Soc Sci Med 2012, 75:1400-1407.
• [65]Slabbert M, Pepper M: “A Room of Our Own?”Legal Lacunae Regarding Genomic Sovereignty in South Africa. Journal of Contemporary Roman-Dutch Law 2010, 73:432.
• [66]Ethnologue, Languages of the World. http://www.ethnologue.com/ webcite
• [67]Chima SC: Regulation of biomedical research in Africa. BMJ 2006, 332:848-851.
• [68]Kass NE, Hyder AA, Ajuwon A, Appiah-Poku J, Barsdorf N, Elsayed DE, Mokhachane M, Mupenda B, Ndebele P, Ndossi G, Sikateyo B, Tangwa G, Tindana P: The structure and function of research ethics committees in Africa: a case study. PLoS Med 2007, 4:e3.
• [69]Nyika A, Kilama W, Chilengi R, Tangwa G, Tindana P, Ndebele P, Ikingura J: Composition, training needs and independence of ethics review committees across Africa: are the gate-keepers rising to the emerging challenges? J Med Ethics 2009, 35:189-193.
• [70]The South African National Accreditation System. http://www.sanas.co.za/ webcite
• [71]Beighton P, Fieggen K, Wonkam A, Ramesar R, Greenberg J: UCT’s contribution to medical genetics in Africa - from the past into the future. S Afr Med J 2012, 102:446-448.
• [72]Southern African Society for Human Genetics (SASHG). http://www.sashg.org/ webcite
• [73]Yu J, Crouch J, Jamal S, Tabor H, Bamshad M: African American attitudes toward exome and whole genome sequencing (Program 148). San Francisco, CA: Presented at the 62nd Annual Meeting of The American Society of Human Genetics; 2012.
• [74]The 1000 genomes project: A deep catalog of human genetic variation . http://www.1000genomes.org/ webcite
• [75]MalariaGEN: Genomic Epidemiology Network. http://www.malariagen.net/ webcite
• [76]Hammond E, Mayet M: Genes From Africa: The Colonisation of Human DNA. South Africa: African center for Biosafety; 2009.
• [77]Marshall PA, Adebamowo CA, Adeyemo AA, Ogundiran TO, Vekich M, Strenski T, Zhou J, Prewitt TE, Cooper RS, Rotimi CN: Voluntary participation and informed consent to international genetic research. Am J Public Health 2006, 96:1989-1995.
• [78]Tekola F, Bull SJ, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, Davey G: Tailoring consent to context: designing an appropriate consent process for a biomedical study in a low income setting. PLoS Negl Trop Dis 2009, 3:e482.
• [79]Marsh VM, Kamuya DM, Mlamba AM, Williams TN, Molyneux SS: Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya. BMC Med Ethics 2010, 11:13. BioMed Central Full Text
• [80]Schuster SC, Miller W, Ratan A, Tomsho LP, Giardine B, Kasson LR, Harris RS, Petersen DC, Zhao F, Qi J, Alkan C, Kidd JM, Sun Y, Drautz DI, Bouffard P, Muzny DM, Reid JG, Nazareth LV, Wang Q, Burhans R, Riemer C, Wittekindt NE, Moorjani P, Tindall EA, Danko CG, Teo WS, Buboltz AM, Zhang Z, Ma Q, Oosthuysen A: Complete Khoisan and Bantu genomes from southern Africa. Nature 2010, 463:943-947.
• [81]MalariaGEN: A global network for investigating the genomic epidemiology of malaria. Nature 2008, 456:732-737.
• [82]Parker M, Bull SJ, De Vries J, Agbenyega T, Doumbo OK, Kwiatkowski DP: Ethical data release in genome-wide association studies in developing countries. PLoS Med 2009, 6:e1000143.
• [83]Warren SD, Brandeis LD: The right to privacy. Harv Law Rev 1890, 4:193-220.
• [84]The Presidential Commission for the Study of Bioethical Issues: Privacy and Progress in Whole Genome Sequencing. http://bioethics.gov/cms/node/764 webcite
• [85]Godard B, Raeburn S, Pembrey M, Bobrow M, Farndon P, Aymé S: Genetic information and testing in insurance and employment: technical, social and ethical issues. Eur J Hum Genet 2003, 11:S123-S142.
• [86]Van Der Merwe D, Roos A, Pistorius T, Eiselen S: Information and Communication Technology Law. Durban: LexisNexis; 2008.
• [87]Zaidi K: Harmonizing US-EU Online Privacy Laws: Toward a US Comprehensive Regime for the Protection of Personal Data. Mich. St. J. Int’l L 2003, 12:169.
• [88]European Commission: Overview on Binding Corporate rules. http://ec.europa.eu/justice/data-protection/document/international-transfers/binding-corporate-rules/index_en.htm webcite
• [89]Forgó N, Kollek R, Arning M, Kreugel T, Petersen I: Ethical and Legal Requirements for Transnational Genetic Research. 1st edition. Munich: C.H. Beck; 2010.
• [90]Tindana P, Bull S, Amenga-Etego L, De Vries J, Aborigo R, Koram K, Kwiatkowski D, Parker M: Seeking consent to genetic and genomic research in a rural Ghanaian setting: A qualitative study of the MalariaGEN experience. BMC Med Ethics 2012, 13:15. BioMed Central Full Text
• [91]De Vries J, Pepper M: Genomic sovereignty and the African promise: mining the African genome for the benefit of Africa. J Med Ethics 2012, 38:474-478.
• [92]Wonkam A, Muna W, Ramesar R, Rotimi CN, Newport MJ: Capacity-building in human genetics for developing countries: initiatives and perspectives in sub-Saharan Africa. Public Health Genomics 2010, 13:492-494.
• [93]The New York Times: Genes Now Tell Doctors Secrets They Can’t Utter. http://www.nytimes.com/2012/08/26/health/research/with-rise-of-gene-sequencing-ethical-puzzles.html?smid=pl-share&_r=0 webcite
• [94]iTunes: MyGenome by Illumina for iPad. https://itunes.apple.com/us/app/mygenome/id516405838?mt=8 webcite
• [95]Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Research Program (U01). http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-12-005.html webcite
• [96]De Vries J, Slabbert M, Pepper MS: Ethical, legal and social issues in the context of the planning stages of the Southern African Human Genome Programme. Med Law 2012, 31:119-152.
• [97]EAGER-Africa: EAGER-Africa. http://eager-africa.com/ea/ webcite
• [98]Drögemöller BI, Wright GEB, Niehaus DJH, Emsley RA, Warnich L: Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications. Pharmacogenomics 2011, 12:1717-1728.